Literature DB >> 28467403

Building the patient community.

F Raffai1, O Timmis2.   

Abstract

There are many challenges in conducting rare disease research. The conditions are often poorly understood, small patient populations are dispersed around the world, and there are limited funding opportunities. Patient groups can serve as a key partner in overcoming these challenges, as they understand the impact of rare conditions on patients' lives. This gives patient groups valuable scientific insights into the disease. This can be used to create research strategies, address research bottlenecks and directly fund research that appropriately addresses patient needs. Patient groups can also play a critical role in recruiting and retaining patients for clinical trials, which reduces time and resource waste. By partnering with patient groups, research teams can improve efficiency of research and best meet the needs of patients. Researchers can also play an important role in building and supporting patient groups to unlock these benefits.

Entities:  

Mesh:

Year:  2017        PMID: 28467403     DOI: 10.1038/gt.2017.33

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  3 in total

1.  Meet the researchers: an alternative method of engaging patients with research in mesothelioma.

Authors:  Kate Hill; Mags Portman; Zsuzsanna Tabi
Journal:  Res Involv Engagem       Date:  2018-10-15

Review 2.  Multiple Sulfatase Deficiency: A Disease Comprising Mucopolysaccharidosis, Sphingolipidosis, and More Caused by a Defect in Posttranslational Modification.

Authors:  Lars Schlotawa; Laura A Adang; Karthikeyan Radhakrishnan; Rebecca C Ahrens-Nicklas
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

3.  Perspectives of people with inherited retinal diseases on ocular gene therapy in Australia: protocol for a national survey.

Authors:  Heather G Mack; Fred K Chen; John Grigg; Robyn Jamieson; John De Roach; Fleur O'Hare; Alexis Ceecee Britten-Jones; Myra McGuinness; Nicole Tindill; Lauren Ayton
Journal:  BMJ Open       Date:  2021-06-22       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.